Go to the list of all blogs
Jimmy Landsman's Avatar
published in Blogs
Sep 09, 2026
CRMG: Salesforce (CRM) AI Momentum Delivers +58% Gains Over 30 Days

CRMG: Salesforce (CRM) AI Momentum Delivers +58% Gains Over 30 Days

Key Takeaways

  • CRMG, a 2x daily leveraged single-stock ETF tied to Salesforce (CRM), climbed roughly 58% over the past 30 days.
  • The advance was concentrated around a single catalyst: Salesforce's fiscal Q2 2027 results and its new "Claudeforce" AI partnership with Anthropic, which pushed CRM up about 22.6% in one session.
  • Because the fund resets its 2x exposure daily, that underlying surge translated into a one-day gain of roughly 44% for CRMG.
  • Over the trailing three months, CRMG rose approximately 67%, recovering sharply from a mid-year trough as Salesforce staged a powerful rally.
  • With a 0.78% net expense ratio and exposure achieved almost entirely through total-return swaps, CRMG is highly volatile and built for short-term trading, not buy-and-hold positioning.

CRMG Structure and How It Tracks Salesforce

CRMG is an actively managed, non-diversified leveraged ETF that seeks to deliver 200% (2x) of the daily price performance of Salesforce (CRM) common stock, before fees and expenses. Rather than holding shares directly, the fund obtains its exposure through total-return swaps on Salesforce, with the remaining portfolio held as cash and U.S. Treasury money-market collateral. In practice, its roughly six reported positions consist of several Salesforce swap agreements plus cash offsets, producing net long equity exposure near 196%.

The fund carries a net expense ratio of 0.78% and is a comparatively small product, with assets under management (AUM) in the tens of millions of dollars. Its daily reset feature is central to understanding its behavior: the 2x multiple applies to a single day's move and is rebalanced each session. Over multi-day holding periods, compounding and volatility can cause returns to diverge meaningfully from two times the underlying stock's cumulative performance. This structure explains why a one-day, roughly 22.6% rally in Salesforce translated into an outsized single-day move in CRMG, and why the fund's longer-term path is highly sensitive to the timing and magnitude of each day's fluctuations. I also checked this using Tickeron’s AI Screener to see how the fund compares to other leveraged products in the space.

CRMG Price Performance Over the Past 30 Days and Quarter

Measured on adjusted closing prices, CRMG rose from about $5.94 to roughly $9.39 over the trailing 30 days, a gain of approximately 58%. The move was not gradual. The fund traded in a relatively contained range through much of the period before gapping sharply higher in late August, when Salesforce reported earnings. Most of the 30-day gain was captured in a single session, underscoring how event-driven and trend-dependent this leveraged product can be.

Over the trailing quarter, the picture is similarly strong but even more volatile. From a closing level near $5.61 in early June, CRMG advanced roughly 67% to its most recent close. That three-month path included a pronounced drawdown into the mid-June lows, a partial recovery through July, and then a decisive breakout following the late-August earnings catalyst. The fund's quarterly performance therefore reflects a sharp rebound rather than a steady uptrend.

The Catalyst Behind the Recent Move in CRMG

The dominant driver was Salesforce's fiscal Q2 2027 report and accompanying AI announcement. Salesforce delivered revenue of $11.35 billion, up about 11% year over year, and adjusted earnings per share (EPS) of $5.90, far above the consensus estimate of roughly $3.27. Free cash flow rose 81% to about $1.1 billion, and current remaining performance obligations (cRPO) climbed 14% in constant currency. Management also raised full-year guidance, lifting its adjusted EPS outlook materially.

Equally important was the strategic news. Salesforce unveiled "Claudeforce," a deepening of its partnership with AI developer Anthropic that integrates Claude's reasoning capabilities into Salesforce's customer data and workflows. The company also reported that Agentforce and Data 360 annual recurring revenue (ARR) approached $3.9 billion, up more than 210% year over year, with Agentforce ARR exceeding $1.5 billion. The combination of a beat-and-raise quarter and a clearer AI monetization story drove CRM up roughly 22.6% in a single session — its largest one-day gain in years — and, through CRMG's 2x daily leverage, produced a correspondingly amplified move in the fund.

Quarterly Trends and the Broader AI Rotation

The three-month trend reflects a broader rotation in the software and AI theme. Salesforce entered the period under pressure, weighed down by concerns that generative AI could disrupt traditional software vendors. Those fears drove CRM and, in turn, CRMG to multi-month lows in June. Sentiment began to stabilize in July as evidence of AI-related demand accelerated, and Salesforce's earnings report ultimately reframed the narrative from "AI disruption risk" to "AI monetization opportunity."

Underlying fundamentals supported the turnaround: expanding gross and net margins, stronger free cash flow, disciplined share buybacks, and accelerating cRPO growth. For a leveraged single-stock vehicle such as CRMG, these longer-term shifts matter only insofar as they shape the daily price moves of the underlying equity — but the quarter's net gain is a direct reflection of Salesforce's recovery and the market's re-rating of enterprise-software leaders with visible AI traction. From what I see, this kind of narrative shift often shows up clearly when screening for momentum in the sector.

Key Factors to Watch for CRMG Going Forward

Several factors will likely shape CRMG's path in the coming months. The most direct is Salesforce's fundamental execution: continued growth in Agentforce and Data 360 ARR, the progression of cRPO, margin expansion, and the early adoption of Claudeforce following its broader rollout. Salesforce's forward guidance and any commentary on enterprise AI spending will be closely watched at future earnings reports.

On the macro side, interest-rate expectations and equity-market risk appetite remain relevant, because valuations for high-multiple software names and the daily volatility that drives a leveraged ETF are both sensitive to shifts in rates and sentiment. Investors should also account for the structural risks unique to CRMG, including volatility decay from daily resetting, the costs embedded in swap financing, concentration in a single underlying stock, and the fund's relatively modest AUM and liquidity. These characteristics make the product most suitable for experienced traders with short holding periods and a high tolerance for loss, rather than long-term investors seeking diversified equity exposure. I'm watching this closely because the daily reset can create significant divergence over longer periods.

Integrating Tickeron’s AI Screener Into My Workflow

When analyzing leveraged products like CRMG, I often turn to Tickeron’s AI Screener to quickly surface comparable ETFs and single-stock vehicles based on volatility, momentum, and sector filters. It helps me cross-check technical patterns and performance metrics without manually sorting through dozens of names. In this case, it confirmed how CRMG’s daily reset and swap-based structure set it apart from broader leveraged equity products. The platform’s AI signals and industry breakdowns give a clearer view of where these instruments sit relative to peers, which is useful when volatility is this elevated.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: CRMG

Contributor

My name is Jimmy, and I’m a financial analyst focused on identifying compelling opportunities across the ETF market. Each day, I analyze hundreds of ETFs to uncover potential trading and investment opportunities using a broad range of market factors. For short-term trading, I rely heavily on technical analysis, including price channels, momentum indicators, support and resistance levels, trend patterns, and other market signals. At the same time, I dedicate significant attention to evaluating ETFs from a long-term investment perspective. My objective is to build a well-balanced ETF portfolio that combines core investment holdings with more tactical and speculative positions. The goal is to create a portfolio that can participate effectively in market rallies while also remaining resilient during periods of volatility and market corrections.


CRMG sees its Stochastic Oscillator recovers from oversold territory

On October 01, 2026, the Stochastic Oscillator for CRMG moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 17 instances where the indicator left the oversold zone. In 17 of the 17 cases the stock moved higher in the following days. This puts the odds of a move higher at over 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a +9.79% 3-day Advance, the price is estimated to grow further. Considering data from situations where CRMG advanced for three days, in 72 of 84 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.

The Aroon Indicator entered an Uptrend today. In 26 of 28 cases where CRMG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.

Bearish Trend Analysis

The 10-day RSI Indicator for CRMG moved out of overbought territory on September 08, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 5 similar instances where the indicator moved out of overbought territory. In 5 of the 5 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.

The Momentum Indicator moved below the 0 level on September 15, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CRMG as a result. In 20 of 21 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

The Moving Average Convergence Divergence Histogram (MACD) for CRMG turned negative on September 10, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 10 similar instances when the indicator turned negative. In 10 of the 10 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRMG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

Notable companies

The most notable companies in this group are Salesforce (NYSE:CRM).

Industry description

The investment seeks daily levered investment results, before fees and expenses, of two times (200%) of the daily percentage change in the price of the common stock of CRM. The fund is an actively managed ETF. It invests at least 80% of its net assets (plus borrowings for investment purposes) in financial instruments with economic characteristics that, in combination, provide 200% daily leveraged exposure to the price of CRM, consistent with the fund’s investment objective. The fund is non-diversified.

High and low price notable news

The average weekly price growth across all stocks in the Leverage Shares 2X Long CRM Daily ETF (CRMG) ETF was 2%. For the same ETF, the average monthly price growth was -23%, and the average quarterly price growth was 40%. CRM experienced the highest price growth at 1%, while CRM experienced the biggest fall at 1%.
View a ticker or compare two or three
CRMG
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category Trading

Category
Trading--Leveraged Equity
Address
United States
Phone
N/A
Web
www.ThemesETFs.com
Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
I've been following CG Oncology, Inc. (CGON), a late-stage clinical biopharmaceutical company dedicated to developing and commercializing cretostimogene grenadenorepvec. This investigational oncolytic immunotherapy aims to serve as a bladder-sparing therapeutic for patients with non-muscle invasive bladder cancer (NMIBC). The company's focus remains on pushing this intravesical therapy through Phase 3 trials to address high unmet needs in BCG-unresponsive and intermediate-risk NMIBC, where treatments like BCG frequently fall short. In the broader biotech landscape, CG Oncology stands out with cretostimogene's encouraging durability and tolerability, which could position it as a foundational therapy. From what I see, these solid fundamentals—bolstered by strong clinical data and regulatory steps—have directly supported the recent stock price gains amid positive trial developments.
From what I see, Home Depot (HD) remains the world's largest home improvement retailer, operating over 2,300 stores across North America with a broad selection of products for construction, renovation, and maintenance. The company blends big-box retail with an expanding e-commerce platform and tailored services for professional contractors, drawing revenue from both do-it-yourself (DIY) consumers and do-it-for-me (DIFM) pros. In a competitive landscape against players like Lowe's, HD maintains dominance through its scale, efficient supply chain, and strong loyalty programs. Much of its performance ties directly to the housing market—home sales, remodeling, and repairs—which explains the recent pressure on the stock from subdued activity and high mortgage rates limiting turnover and major projects.
GE Aerospace (GE) stock declined -12% over the past 30 days, falling from around $333 to $293, amid profit-taking after record highs near $348. Over the past quarter, the stock is down -8%, reflecting post-earnings selloff despite strong Q4 2025 results with 20% revenue growth.
Toyota Motor Corporation (TM) stands as the world's largest automaker by volume, designing, manufacturing, and selling a wide range of vehicles—from sedans and trucks to SUVs and electrified models like hybrids—under brands including Toyota, Lexus, and Daihatsu. The company's business model centers on a robust global supply chain, vertical integration in components like engines and transmissions, and a multi-pathway approach that prioritizes hybrids alongside EVs and hydrogen technology. In the highly competitive automotive sector, Toyota maintains a strong position, particularly with its dominant hybrid market share, though it faces mounting pressure from EV frontrunners such as BYD in China and Tesla worldwide. From what I see, these core strengths explain much of the recent stock action: the resilience from hybrids offers some stability, but the slower EV rollout and heavy China exposure heighten sales volatility in a shifting market.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
Sable Offshore Corp. (SOC) shares fell 7.40% in the most recent completed session, closing at $16.52 versus a prior close of $17.84. The pullback followed a volatile stretch in which SOC traded between $15.76 and $19.21 over just two sessions, reflecting profit‑taking after a strong run in March.
NBR stock rose approximately +12% over the last 30 days, driven by positive momentum in the oil and gas drilling sector and strong Q4 earnings beat. Over the past quarter, the stock surged +58%, fueled by robust YTD performance, debt reduction efforts, and improved operational results in international drilling.
Patterson-UTI Energy, Inc. (PTEN) stands out as a leading provider of drilling and completion services to oil and natural gas exploration and production companies, primarily in the United States and select international markets. The company operates through three main segments: Drilling Services, which includes contract drilling rigs and directional drilling; Completion Services, encompassing hydraulic fracturing, wireline, and pumping; and Drilling Products, offering specialized drill bits globally, including in the Middle East.
As a provider of onshore drilling and completion services, Patterson-UTI Energy (PTEN) is gearing up for a key Q1 2026 earnings report against the backdrop of fluctuating oil prices and steady U.S. rig demand. The company's integrated approach across Drilling Services, Completion Services, and Drilling Products gives it a solid footing in North American shale plays. In my view, recent quarters like Q4 2025, where revenue exceeded estimates despite a net loss, highlight its resilience. This upcoming report will offer insights into activity levels, margin trends, and capital discipline amid supply growth and geopolitical tensions. With strong free cash flow and recent dividend increases, PTEN's focus on shareholders stands out, making this a critical gauge for the 2026 outlook in the cyclical oilfield services sector.
When geopolitical turmoil sends markets into chaos, most retail traders freeze — but Tickeron's Energy (OXY, EOG, DVN, FANG, APA, MTDR) AI Trading Agent is built to thrive in exactly these conditions. This 15-minute and 60-minute AI-powered robot has delivered a +76.22% annualized return with a 64.21% win rate and a Profit Factor of 2.70 — trading six of the most volatile and opportunity-rich energy tickers on the market.
The global energy sector is on fire — literally and figuratively. With crude oil prices swinging 20–30% in response to geopolitical flashpoints, OPEC+ production cuts, and escalating conflicts in Eastern Europe and the Middle East, traders who aren't using AI-powered tools are flying blind. Enter Tickeron's Energy (Oil & Gas – E&P) AI Trading Agent — a 60-minute signal robot built exclusively around five high-impact Exploration & Production tickers, now posting a staggering +49% Annualized Return and +1,251% 30-Day Annualized Return, with $14,703 in closed-trade P&L on a $30,000 simulated balance.